Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection
0
Zitationen
32
Autoren
2026
Jahr
Abstract
FOLFIRINOX appears the most effective option for carefully selected, fit patients eligible for 2L chemotherapy after GnP failure. Interpretable artificial intelligence-derived treatment policies may provide superior net clinical benefit compared to uniform approaches and guide individualized therapy, warranting integration with upcoming targeted strategies such as RAS inhibitors.
Ähnliche Arbeiten
The Clavien-Dindo Classification of Surgical Complications
2009 · 11.007 Zit.
Radiomics: Images Are More than Pictures, They Are Data
2015 · 8.024 Zit.
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 · 7.633 Zit.
TGF-β SIGNAL TRANSDUCTION
1998 · 7.559 Zit.
Pancreatic Cancer
2000 · 7.244 Zit.
Autoren
- Letizia Procaccio
- Guido Giordano
- Federico Nichetti
- Michele Milella³
- Andrea Pretta
- Donatella Iacono
- M. Niger
- Simona Casalino
- C. Vivaldi
- Ferdinando De Vita
- Valeria Pusceddu
- Matteo Landriscina
- Giacomo Di Paolo
- S. Sperotto
- Mariachiara Masucci
- Giampaolo Tortora
- R. Bianco
- Enrico Vasile
- Alberto Zaniboni
- Chiara Carmen Miceli
- Elena Ongaro
- Elisa Giommoni
- Gabriele Tinè
- Giulia Barsotti
- Silvia Marchesi
- Mariacristina Di Marco
- Silvia Ortolani
- Giuseppe Aprile
- M. Scartozzi
- Francesca Bergamo
- Davide Melisi³
- Sara Lonardi
Institutionen
- Istituto Oncologico Veneto(IT)
- University of Foggia(IT)
- Ospedali Riuniti di Foggia(IT)
- University of Verona(IT)
- University of Cagliari(IT)
- University of Udine(IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
- Azienda Ospedaliera Universitaria Integrata Verona(IT)
- University of Pisa(IT)
- Azienda Ospedaliera Universitaria Pisana(IT)
- University of Campania "Luigi Vanvitelli"(IT)
- Università Cattolica del Sacro Cuore(IT)
- Agostino Gemelli University Polyclinic(IT)
- Federico II University Hospital(IT)
- University of Naples Federico II(IT)
- Fondazione Poliambulanza Istituto Ospedaliero(IT)
- Centro di Riferimento Oncologico(IT)
- Azienda Ospedaliero-Universitaria Careggi(IT)
- Azienda USL di Bologna(IT)
- University of Bologna(IT)
- Casa di Cura Villa Garda(IT)